According to an embodiment of the present disclosure, Ar1 is a tetra-valent organic group having a monocyclic alicyclic hydrocarbon structure or a bridged-ring alicyclic hydrocarbon structure.
According to another embodiment of the present disclosure, Ar2 is a di-valent organic group having a monocyclic alicyclic hydrocarbon structure.